Novonix Ltd
F:GC3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novonix Ltd
F:GC3
|
AU |
|
X4 Pharmaceuticals Inc
F:48Q
|
US |
|
S
|
Swedish Orphan Biovitrum AB (publ)
SWB:B6E
|
SE |
|
L
|
Lepidico Ltd
F:AUB
|
AU |
|
S
|
secunet Security Networks AG
XMUN:YSN
|
DE |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
Y
|
YPF SA
SWB:YPF
|
AR |
|
S
|
Seek Ltd
F:SLD
|
AU |
|
Axsome Therapeutics Inc
F:19X
|
US |
|
T
|
Toll Brothers Inc
XMUN:TLK
|
US |
|
Nexa Resources SA
F:NE0
|
LU |
|
C
|
Crest Nicholson Holdings PLC
F:C38
|
UK |
|
H
|
Haseko Corp
F:HS6
|
JP |
|
C
|
Carabao Group PCL
SET:CBG
|
TH |
|
A
|
Amkor Technology Inc
F:AMK
|
US |
|
L
|
La-Z-Boy Inc
F:LAZ
|
US |
Shareholder Yield
Current shareholder yield for 
GC3 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GC3 Price
Novonix Ltd
| Average Annual Return | 41.22% |
| Standard Deviation of Annual Returns | 177.34% |
| Max Drawdown | -98% |
| Market Capitalization | 214.2m EUR |
| Shares Outstanding | 492 734 016 |
| Percentage of Shares Shorted |
N/A
|
